Surgery – Diagnostic testing – Detecting nuclear – electromagnetic – or ultrasonic radiation
Reexamination Certificate
2002-04-26
2010-02-16
Casler, Brian (Department: 3737)
Surgery
Diagnostic testing
Detecting nuclear, electromagnetic, or ultrasonic radiation
C600S407000, C600S429000, C600S427000, C600S436000, C378S015000, C378S019000, C378S062000, C378S064000, C606S130000
Reexamination Certificate
active
07664543
ABSTRACT:
A CT scanner and method are designed to scan a preselected portion of a patient's lower abdomen. The scanner may include a source and detector array designed to rotate about a rotation axis oriented substantially parallel to or coincident with the hips of the a patient so that a scanning plane does not pass through the patient's pelvic bones Higher-resolution image CT images can be achieved by using a detector array of the type used for digital radiography. The presence of prostatic cancer can be detected by first injecting the patient with a material including a high contrast material for X-ray imaging and a material for binding the high contrast material to a specific biological site if present in the preselected portion of the lower abdomen of the patient; and generating a CT image of the preselected portion of the lower abdomen.
REFERENCES:
patent: 3927326 (1975-12-01), Kunne et al.
patent: 4503331 (1985-03-01), Kovacs et al.
patent: 4547893 (1985-10-01), Gordon
patent: 4870279 (1989-09-01), Cueman et al.
patent: 4961208 (1990-10-01), Okada
patent: 5109397 (1992-04-01), Gordon et al.
patent: 5114703 (1992-05-01), Wolf et al.
patent: 5141739 (1992-08-01), Jung et al.
patent: 5391879 (1995-02-01), Tran et al.
patent: 5438602 (1995-08-01), Crawford
patent: 5468465 (1995-11-01), Deutsch et al.
patent: 5574763 (1996-11-01), Dehner
patent: 5796802 (1998-08-01), Gordon
patent: 5848117 (1998-12-01), Urchuk et al.
patent: 6017703 (2000-01-01), Kinders et al.
patent: 6019957 (2000-02-01), Miller et al.
patent: 6090559 (2000-07-01), Russell et al.
patent: 6136311 (2000-10-01), Bander
patent: 6171796 (2001-01-01), An et al.
patent: 6292529 (2001-09-01), Marcovici et al.
patent: 6366796 (2002-04-01), Yanof et al.
patent: 6400791 (2002-06-01), Schwarz
patent: 6487438 (2002-11-01), Widmark et al.
patent: 6735274 (2004-05-01), Zahavi et al.
patent: 7167538 (2007-01-01), Strobel et al.
patent: 7224764 (2007-05-01), Sukovic et al.
patent: WO 02/11771 (2002-02-01), None
Ralph Weissleder, et al., “Molecular Imaging”, Molecular analysis Radiology and radiologists, Research Review, Radiology 2001, vol. 219 No. 2, pp. 316-333, 2001.
A.R. Bradwell, et al., “Developments in Antibody Imaging”, Monoclonal Antibodies for Cancer Detection and Therapy, Chapter 4, pp. 65-85, 1985.
Judd W. Moul, et al., “The Role Of Imaging Studies And Molecular Markers For Selecting Candidates For Radical Prostatectomy”, Urologic Clinics Of North America, Radical Prostatectomy, vol. 28, No. 3, pp. 459-472, Aug. 2001.
Alan W. Partin, et al., “The Clinical Usefulness Of Prostate Specific Antigen: Update 1994”, The Journal Of Urology, vol. 152, 1358-1368, Nov. 1994.
Akhouri A Sinha, “Intravenous Injection of an Immunoconjugate (anti-PSA-IgG Conjugated to 5-Fluoro-2′-deoxyuridine) Selectively Inhibits Cell Proliferation and Induces Cell Death in Human Prostate Cancer Cell Tumors Grown in Nude Mice”, Anticancer Research 19, pp. 893-902, 1999.
Catherine C. Boring, “Cancer Statistics, 1993”, CA-Cancer J. Pract., vol. 43, No. 1, pp. 7-8, Jan./Feb. 1993.
G. Frens, “Controlled Nucleation For The Regulation Of The Particles Size In Monodisperse Gold Suspensions”, Nature Physical Science, vol. 241, pp. 2-4, Jan. 1, 1973.
G. Dhom, “Epidemiologic Aspects of Latent and Clinically Manifest Carcinoma of the Prostate”, Cancer Res. Clin. Oncol., 106:210-218, 1983.
H. Ballentine Carter, et al., “The Prostate: An Increasing Medical Problem”, The Prostatc 16:39-48, 1990.
Ganesh V. Raj, et al., “Clinical Utility of Indium 111-Capromab Pendetide Immunoscintigraphy in the Detection of Early, Recurrent Prostate Carcinoma after Radical Prostatectomy”, Cancer, vol. 94, No. 4, pp. 987-996, Feb. 15, 2002.
Daniel Kahn, et al., “Radioimmunoscintigraphy With In-111-Labeled Capromab Pendetide Predicts Prostate Cancer Response to Salvage Radiotherapy After Failed Radical Prostatectomy”, Journal of Clinical Oncology, vol. 16, No. 1, pp. 284-289, Jan. 1998.
S. Kirac, et al., “Detection of Metastatic Bone Lesions in Patients with Prostate Carcinoma:99Tcm-monoclonal antibody imaging”, Nuclear Medicine Communications, vol. 18, pp. 968-973, 1997.
Daniel Kahn, et al., “111Indium-Capromab Pendetide In The Evaluation Of Patients With Residual Or Recurrent Prostate Cancer After Radical Prostatectomy”, The Journal Of Urology, vol. 159, pp. 2041-2047, Jun. 1998.
Akhouri A. Sinha, et al., “Plasma Membrane Association of Cathepsin B in Human Prostate Cancer: Biochemical and Immunogold Electron Microscopic Analysis”, The Prostate 49: 172-184, 2001.
Harriet M. Lamb, et al., “Capromab Pendetide-A Review of its Use as an Imaging Agent in Prostate Cancer”, Drugs & Aging, Apr. 12, 1998 (4) 293-304.
Rodney J. Ellis, et al., “Radioimmunoguided Imaging Of Prostate Cancer Foci With Histopathological Correlation”, Int. J. Radiation Oncology Biol. Phys., vol. 49, No. 5, pp. 1281-1286, 2001.
G.P. Murphy, et al., “The National Survey Of Prostate Cancer In The United States By The American College Of Surgeons”, The Journal Of Urology, vol. 127, pp. 928-934, May 1982.
Timo Phronen, et al., “Immunofluorometric Assay For Sensitive And Specific Measurement Of Human Prostatic Glandular Kallikrein (hK2) In Serum”, Clinical Chemistry 42:7, 1034-1041, 1996.
Julius S. Horoszewicz, et al., Monoclonal Antibodies to a New Antigenic Marker in Epithelial Prostatic Cells and Serum of Prostatic Cancer Patients, Anticancer Research 7:927-936, 1987.
Thomas C. Gasser, et al., “MRI And Ultrasonography In Staging Prostate Cancer”, The New England Journal Of Medicine, pp. 494-495, Feb. 14, 1991.
David A. Silver, et al., “Prostate-specific Membrane Antigen Expression in Normal and Malignant Human Tissues”, Clinical Cancer Research, vol. 3, pp. 81-85, Jan. 1997.
Ron S. Israeli, et al., “Expression of the Prostate-Specific Membrane Antigen”, Cancer Research, vol. 54, pp. 1807-1811, Apr. 1, 1994.
Matthew D. Rifkin, et al., “Comparison of Magnetic Resonance Imaging and Ultrasonography in Staging Early Prostate Cancer”, The New England Journal of Medicine, Val. 323, No. 10, pp. 623-626, Sep. 6, 1990.
Gerald P. Murphy, et al., “Evaluation and Comparison of Two New Prostate Carcinoma Markers”, Cancer, vol. 78, No. 4, pp. 809-818, Aug. 15, 1996.
Ruth E. Carter, et al., “Prostate-Specific Membrane Antigen is a Hydrolase with Substrate and Pharmacologic Characteristics of a Neuropeptidase”, Neurobiology, Proc. Natl. Acad. Sci. USA, vol. 93, pp. 749-753, Jan. 1996.
G.P. Murphy, et al., “Comparison of Prostate Specific Antigen, Prostate Specific Membrane Antigen, and LNCaP-Based Enzyme-Linked Immunosorbent Assays in Prostatic Cancer Patients and Patients With Benign Prostatic Enlargement”, The Prostate 26:164-168, 1995.
Chia-Ling Huang, et al., “Comparison of Prostate Secretory Protein With Prostate Specific Antigen and Prostatic Acid Phosphatase as a Serum Biomarker for Diagnosis and Monitoring Patients With Prostate Carcinoma”, The Prostate 23: 201-212, 1993.
Catherine C. Boring, et al., “Cancer Statistics, 1993”, CA Cancer J Clin., 43: 7-26, 1993.
Phyllis A. Wingo, et al., “An Adjustment to the 1997 Estimate for New Prostate Cancer Cases”, CA Cancer J Clin. 47: 239-242, 1997.
Analogic Corporation
Casler Brian
McDermott Will & Emery LLP
Ramirez John F
LandOfFree
CT scanner for and method of imaging a preselected portion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CT scanner for and method of imaging a preselected portion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CT scanner for and method of imaging a preselected portion... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4156887